CD55 and CD59 expression protects HER2-overexpressing breast cancer cells from trastuzumab-induced complement-dependent cytotoxicity
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 12
(02)
◽
Keyword(s):
2017 ◽